PBD Podcast cover image

Big Pharma EXPOSED: Dr. John Abramson | PBD Podcast Ep. 351

PBD Podcast

00:00

Conflicts of Interest in Drug Efficacy Monitoring

This chapter examines the FDA's controversial approval of a new drug based on statistical significance, highlighting the potential financial implications for taxpayers. It also explores the concerns surrounding different data registries and the possible biases in the monitoring of the drug's effectiveness.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app